A Versatile EGFR and MET Bispecific Antibody for Diverse Clinical Applications
The following is a summary of the “Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad…